Shen Zeren, Shao Jinjin, Dai Jiabin, Lin Yuchen, Yang Xiaochun, Ma Jian, He Qiaojun, Yang Bo, Yao Ke, Luo Peihua
Institute of Pharmacology & Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China.
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, P.R. China.
Toxicol Rep. 2015 Dec 17;3:78-86. doi: 10.1016/j.toxrep.2015.12.004. eCollection 2016.
Visual impairment is a global public health problem that needs new candidate drugs. is a traditional Chinese drug, famous for its eye-protective function, with an unclear mechanism of action. To determine how contributes to vision, we identified, for the first time, the component of , diosmetin (DIO), which acts in protecting the injured retina in an adriamycin (ADR) improving model. We observed that DIO could attenuate the apoptosis of retinal cells in Sprague-Dawley rats and verified this effect in cultured human retinal pigment epithelium (RPE) cells, ARPE-19. Our further study on the mechanism revealed the counteractive effect of DIO on the attenuation of DNA damage and oxidative stress, which occurs in a wide range of retinal disorders. These results collectively promise the potential value of DIO as a retinal-protective agent for disorders that lead to blindness. In addition, we identified, for the first time, the component of , DIO, which acts in protecting the injured retina.
视力障碍是一个需要新型候选药物的全球性公共卫生问题。[药物名称]是一种传统中药,以其护眼功能而闻名,但其作用机制尚不清楚。为了确定[药物名称]如何对视力产生影响,我们首次鉴定出[药物名称]的成分香叶木素(DIO),它在阿霉素(ADR)改善模型中对受损视网膜具有保护作用。我们观察到DIO可以减轻Sprague-Dawley大鼠视网膜细胞的凋亡,并在培养的人视网膜色素上皮(RPE)细胞ARPE-19中证实了这一作用。我们对其机制的进一步研究揭示了DIO对DNA损伤和氧化应激减轻的对抗作用,而DNA损伤和氧化应激在多种视网膜疾病中都会发生。这些结果共同表明DIO作为一种用于导致失明的疾病的视网膜保护剂具有潜在价值。此外,我们首次鉴定出[药物名称]的成分DIO,它对受损视网膜具有保护作用。